Skip to content
etf.net

Launched

Harbor Health Care ETF (MEDI)

MEDINYSE ArcaD

$31.78−0.58 (−1.79%)

As of Oct 13, 2026, 3:59 PM

D37/ 100

Rank 29 of 35 in US Active Sector

D37/100Rank 29 of 35inUS Active Sector
Intraday session: down, 77 prints from 32.36 to 31.78. Range 31.76 to 32.42. Use the arrow keys to read each point.31.9032.0032.1032.2010 AM12 PM2 PM4 PM
Expense ratio
0.80%
Fund size
$41M
1Y total return
+10.1%
Yield · Last 12 months
0.23%
Holdings
45
Avg volume · 30D
0M sh
NAV per share
$32.36
52W range
low $27.50high $35.60
Launched

The ETF.net MEDI Grade

D

Score 37 out of 100

Category
US Active Sector⁠
Rank
29 of 35
Six-pillar profile for MEDI. Scores out of 100: Cost 26, Risk 36, Mission 59, Tradability 49, Holdings 44, Durability 56. Strongest: Mission (59). Weakest: Cost (26). Leans toward Mission and Durability.

Score 37 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    D26 out of 100
    Rank 25 of 35

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    B59 out of 100
    Rank 7 of 9

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    D36 out of 100
    Rank 25 of 35

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C49 out of 100
    Rank 19 of 35

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C44 out of 100
    Rank 25 of 35

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B56 out of 100
    Rank 16 of 35

Our read on MEDI

ETF.net Research

DRoughly 40 health care stocks, hand-picked across any size, from big pharma to small biotech. It's a concentrated stock-picker's book benchmarked to a growth health care index, not a hold-everything sector basket.

Stated mandate

Seeks long-term growth of capital by primarily investing in common and preferred equity securities of companies of any market capitalization. Normally, at least 80% of net assets plus investment borrowings are invested in companies principally engaged in health care-related products and services.

Why people hold it

  1. 01About 40 names, not hundreds. Each pick has room to matter, which is the whole point of hiring an active manager instead of buying the entire sector.
  2. 02The mandate is explicit: at least 80% of assets in health care companies, any market cap, common or preferred shares. Big pharma and small biotech are both fair game.
  3. 03The yardstick is named up front, the Russell 3000 Growth Health Care Index, so the growth lean is disclosed rather than discovered later.

Worth knowing

  1. 01The 0.80% expense ratio sits above the median for actively managed US equity ETFs, so the stock picking carries a higher bar to clear.
  2. 02This is a small fund that doesn't trade heavily, which can mean wider bid-ask spreads than the giant sector index products.
  3. 03Payouts land once or twice a year, and a 40-stock growth portfolio reacts to single-name drug and trial news far more than a broad sector basket.

MEDI Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
45
Top-10 weight
62%
Largest holding
LLY22.5%

Sectors

  • Health Care100.0%

Geography

  • United States76.05%
  • Denmark15.66%
  • Netherlands4.84%
  • France1.79%
  • Canada1.24%
  • Switzerland0.42%

Developed 100% · Emerging 0% of the foreign sleeve

The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001LLYEli Lilly & Co22.50%7,883$9M583
002—Ascendis Pharma A/S16.14%29,093$7M1
003ARGNFArgenx SE - Adr4.55%2,277$2M12
004PCVXVaxcyte Inc3.78%21,881$2M109
005INSMInsmed Inc2.94%12,084$1M192
006RYTMRhythm Pharmaceuticals Inc2.85%12,960$1M82
007ABBVAbbVie Inc2.43%3,635$1M522
008GHGuardant Health Inc2.37%5,849$980K175
009NTRANatera Inc2.34%2,415$968K238
010DHRDanaher Corp2.15%4,043$889K331
011RVMDRevolution Medicines Inc2.07%4,504$855K176
012MCKMckesson Corp1.93%851$799K359
013PTCTPtc Therapeutics Inc1.88%11,975$775K130
014IDXXIdexx Laboratories Inc1.80%1,432$742K355
015UNHUnitedHealth Group Inc1.78%1,942$737K481

Showing 1–15 of 45 holdings

MEDI Performance

Launched Nov 16, 2022

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.
MEDI$11,011
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. MEDI $11,011. SPY $12,044. Use the arrow keys to read each point.$9,243$10,787$12,330Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for MEDI. Periods over one year show the average yearly return.
PeriodMEDI
Year to date+2.9%
1 month−3.1%
3 months−5.1%
1 year+10.1%
3 yearsper year+15.0%
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for MEDI
YearReturn barMEDI
2026 YTD+2.9%
2025+27.1%
2024+0.6%
2023+24.8%
2022+2.6%

History from Nov 17, 2022

MEDI in the news

Filtered to MEDI · US Active Sector

MEDI Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.23%Last 12 months
Payout per share
$0.08Last 12 months
Last payment
$0.08 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Annual

Distribution history

2023–2026

One bar per payment. 3 payments from 2023 to 2026 YTD. Dec 21, 2023 $0.46; Dec 20, 2024 $0.13; Dec 19, 2025 $0.08. Use the arrow keys to read each point.2023202420252026YTD
Ex-datePay dateAmount per share
Dec 19, 2025Dec 24, 2025$0.08
Dec 20, 2024Dec 26, 2024$0.13
Dec 21, 2023Dec 27, 2023$0.46

MEDI Risk

How much the fund’s monthly returns vary, scaled to a year.
17.9%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.62
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−19.3%
46 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.73
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

MEDI Cost

Expense ratio0.80%
  • The middle half of US Active Sector funds
  • Median 0.65%

26 of the 35 US Active Sector funds charge less.

MEDI costs $80.00 a year on $10,000. The median US Active Sector fund costs $65.00.

Other funds in US Active Sector

See others